Regen BioPharma Inc (RGBP)

[Musical Shares]

I am betting that no one will pay that $50 to actually purchase the report to realize that many who are hyping this do not have the entire story right.

They don't. There is nothing actually new here. Taking things at face value is easier than anything else.

First, Springer is just a book publisher (I am sure people have had books read that were published under Springer.)

Second, Springer in no way, shape or form is publishing "inside" information before it hits the public. Not only is it illegal but Springer wouldn't even know or have access to this information (as one can't just go to a database and see what company is doing pre-clinicals). There is no such thing.

Second, look at the first date: March 10, 2022. Koos put out a PR on that same date!

https://www.prnewswire.com/news-releases/regen-biopharma-inc-announces-program-to-fast-track-its-checkpoint-inhibitor-program-utilizing-modified-mrna-and-sirna-technologies-301499817.html

About that same information.

What people are forgetting is that TcellVax had already been around in pre-clinicals since 2016. Springer would already have that information. It just updated that like it did when it first came out in 2016!

This is what it says exactly on their website: Preclinical development in Breast cancer and Myelodysplastic syndrome is ongoing USA

Third, if people looked at this:

https://adisinsight.springer.com/drugs/800067408

They would notice it says mRNA anti-cancer vaccine - Regen BioPharma.

This is another "drug profile" with Springer.

Guess when the most recent update was? February 11, 2022. Koos put out a PR on that same date!

https://www.prnewswire.com/news-releases/regen-biopharma-inc-to-initiate-development-of-its-modified-mrna-anti-cancer-vaccine-technology-301480653.html

About that same information.